Lametec Kid Tablet DT contains Lamotrigine 5mg, an anticonvulsant medication primarily indicated for the management of epilepsy and seizure disorders in pediatric patients. Lamotrigine acts by stabilizing neuronal membranes through inhibition of voltage-sensitive sodium channels, thereby reducing the release of excitatory neurotransmitters such as glutamate. This mechanism helps to prevent the initiation and spread of seizure activity in the brain. Lametec Kid Tablet DT is formulated as a dispersible tablet, facilitating ease of administration and accurate dosing in children who may have difficulty swallowing conventional tablets. It is commonly prescribed as adjunctive therapy for partial seizures, generalized seizures, and Lennox-Gastaut syndrome. The dosage should be individualized based on patient response and clinical condition, with gradual titration to minimize the risk of adverse effects, including serious skin reactions such as Stevens-Johnson syndrome. Common side effects may include dizziness, headache, nausea, and rash. Lametec Kid Tablet DT should be used under strict medical supervision, with regular monitoring for efficacy and tolerability. It is contraindicated in patients with known hypersensitivity to Lamotrigine or any excipients. Caution is advised when used concomitantly with other antiepileptic drugs due to potential drug interactions.